Phase Ib/IIa, to evaluate the safety and pharmacokinetics of Z-360 in subjects with unresectable advanced pancreatic cancer in combination with gemcitabine treatment
Latest Information Update: 10 Aug 2019
At a glance
- Drugs Z 360 (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Zeria
- 07 Nov 2006 Status change
- 08 Sep 2006 New trial record.